Literature DB >> 18004637

Brain natriuretic peptide as a marker of cardiac toxicity in patients with multiple sclerosis treated with mitoxantrone.

Pierluigi Bertora, Daniela Torzillo, Gabriella Baldi, Tarcisio Vago, Claudio Mariani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18004637     DOI： 10.1007/s00415-007-0689-2

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  3 in total

Review 1.  Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine.

Authors:  Michael Weber; Christian Hamm
Journal:  Heart       Date:  2006-06       Impact factor: 5.994

Review 2.  Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies.

Authors:  Markus Battaglia; Daniel Pewsner; Peter Jüni; Matthias Egger; Heiner C Bucher; Lucas M Bachmann
Journal:  Arch Intern Med       Date:  2006-05-22

3.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Authors:  Alan S Maisel; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Paul Clopton; Philippe G Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Howard C Herrmann; Peter A McCullough
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245
  3 in total
  2 in total

Review 1.  Predictors of Response to Multiple Sclerosis Therapeutics in Individual Patients.

Authors:  Harald Hegen; Michael Auer; Florian Deisenhammer
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

2.  Serial Assessment of Cardiac Function during and following Mitoxantrone Infusion in 30 Consecutive Patients with Multiple Sclerosis.

Authors:  Damian Franzen; Angelika Haus; Martin Hellmich
Journal:  Mult Scler Int       Date:  2010-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.